Parvovirus B19: Implications for transfusion medicine. Summary of a workshop

Transfusion

Volumn 41, Issue 1, 2001, Pages 130-135

  Brown, Kevin E ^a   Young, Neal S ^a   Alving, Barbara M ^a   Barbosa, Luiz H ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANEMIA; BLOOD DONOR; BLOOD TRANSFUSION; CHILDHOOD CANCER; CONFERENCE PAPER; ERYTHEMA INFECTIOSUM; EXPERIMENTAL INFECTION; HIGH RISK POPULATION; HUMAN; INFECTIOUS COMPLICATION; NONHUMAN; PARVOVIRUS; PREGNANCY; RETICULOCYTE COUNT; VIRUS MORPHOLOGY;

ANIMALS; BLOOD; BLOOD TRANSFUSION; HUMANS; PARVOVIRIDAE INFECTIONS; PARVOVIRUS; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION; VIRAL VACCINES;

EID: 0035130271     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.2001.41010130.x     Document Type: Conference Paper

References (39)

1. Parvovirus-like particles in human sera
2. Characterization and molecular cloning of a human parvovirus genome
3. First continuous propagation of B19 parvovirus in a cell line
4. Successful replication of parvovirus B19 in the human megakaryocytic leukemia cell line MB-02
5. Characterization of capsid and noncapsid proteins of B19 parvovirus propagated in human erythroid bone marrow cell cultures
6. Self-assembled B19 parvovirus capsids, produced in a baculovirus system, are antigenically and immunogenically similar to native virions
7. The gene encoding the nonstructural protein of B19 (human) parvovirus may be lethal in transfected cells
8. A block in fulllength transcript maturation in cells nonpermissive for B19 parvovirus
9. Erythrocyte P antigen: Cellular receptor for B19 parvovirus
10. Resistance to parvovirus B19 infection due to lack of virus receptor (erythrocyte P antigen)
11. Parvovirus B19 associated with fetal abnormality
12. Human parvovirus B19 infections in women of childbearing age and within families
13. Experimental parvoviral infection in humans
14. Human parvovirus B19 epidemiology and clinical manifestations
15. Persistent B19 parvovirus infection in patients infected with human immunodeficiency virus type 1 (HIV-1): A treatable cause of anemia in AIDS
16. Human parvovirus B19 infections in infants and children
17. Persistence of parvovirus B 19 DNA in synovial membranes of young patients with and without chronic arthropathy
18. What threat is human parvovirus B19 to the fetus? A review
19. Immediate and long term outcome of human parvovirus B19 infection in pregnancy
20. Human parvovirus B19 antibodies in infantile autism
21. Congenital central nervous system disease following intrauterine parvovirus B19 infection
22. Congenital anaemia after transplacental B19 parvovirus infection
23. Parvovirus infections and hypoplastic crisis in sickle-cell anaemia
24. The role of parvovirus B19 in aplastic crisis and erythema infectiosum (fifth disease)
25. Chronic bone marrow failure due to persistent B19 parvovirus infection
26. Immune response to B19 parvovirus and an antibody defect in persistent viral infection
27. Neutralizing linear epitopes of B19 parvovirus cluster in the VP1 unique and VP1-VP2 junction regions
28. The structure of human parvovirus B19 at 8 A resolution
29. Quantitative analysis of neutralizing immune responses to human parvovirus B19 using a novel reverse transcriptase-polymerase chain reaction-based assay
30. Identification of a novel simian parvovirus in cynomolgus monkeys with severe anemia: A paradigm of human B19 parvovirus infection
31. Hydrops fetalis induced by simian parvovirus
32. Human parvovirus B19: Laboratory diagnosis
33. The transfusion-associated transmission of parvovirus B19
34. Chronic anemia due to parvovirus B19 infection in a bone marrow transplant patient after platelet transfusion
35. Transfusion-transmitted human parvovirus B 19 infection in a thalassemic patient
36. Human parvovirus B19: Prevalence of viral DNA in volunteer blood donors and clinical outcomes of transfusion recipients
37. Screening of blood donors for human parvovirus B19 and characterization of the results
38. Novel human erythrovirus associated with transient aplastic anemia